Puma Biotechnology | Zysk Brutto



Pre Tax Profit Zmiana Data
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Daiichi Sankyo JPY 80.63B 1.78B 2025-03
Exelixis USD 205.69M 20.92M 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 234.19M 172.64M 2025-03
MacroGenics USD -14477000 70.79M 2024-12
Moderna USD -964000000 220M 2025-03
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Takeda JPY -107299000000 133.71B 2025-03
TG Therapeutics USD 25.45M 21.18M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Puma Biotechnology Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.